Statement Issued By The Ministry Of Public Health On The Measures Followed With Regard To The People

Statement Issued by the Ministry of Public Health on the Measures Followed with Regard to the People Coming from China

The Ministry of Public Health issued the following statement on the measures taken with the travelers coming from China:

Upon recommendation of the World health Organization, the Ministry of Public Health is implementing the following measures with the travelers coming from China through the airport:

Thermal screening through devices put in place at the airport to this end.
When the traveler is exposing fever, he is transferred to the quarantine office where test is carried out on him.
An information form is filled by travelers coming from all the Chinese regions who are on board, so as to follow up on them over the phone for two weeks (the incubation period of the virus) to make sure they do not show any symptoms.
The form should be submitted to the plane crew before taking off. In case the form remained with the traveler for any reason whatsoever, it should be handed out to the quarantine office of the Ministry of Public Health at the airport when leaving the plane.
In the event that a traveler coming China shows any symptoms within 14 days, he will be transferred to Rafik Hariri University Hospital for assessment and quarantined there if need be.
The persons coming from the places where the coronavirus originated (Wuhan and some surrounding areas) will be quarantined at Rafik Hariri University Hospital (like what happened with one traveler so far).
The persons coming from all the other areas in China are required to self-quarantined, and avoid contact with people for 14 days as of the day they leave China. They are also advised to call the Ministry of Public Health for any inquiry.
The lab test for coronavirus, which is now available free of charge at Rafik Hariri University Hospital is conducted according to scientific and medical data determined by the Ministry of Public Health.
The measures taken by the Ministry of Public Health are applied according to the recommendation of the World health Organization.
The citizens are called on to collaborate in the implementation of the scientific and health measures required for the infection prevention.
The Ministry of Public Health calls upon the citizens to act responsibly and not to spread rumors or baseless information.

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
J05AH02	VIRIFLU	G	Oseltamivir - 75mg	75mg	Capsule	1,371,615 L.L
A11AA	VITA-GERIN	G	Ginseng extract - 40mg, Vitamin A, palmitate - 2667IU, Vitamin D3 - 200IU, ?-Tocopheryl acetate - 10mg, Thiamine mononitrate - 1.4mg, Riboflavine - 1.6mg, Pyridoxine HCl - 2mg, Cyanocobalamin - 1mcg, Biotin - 150mcg, Nicotinamide - 18mg, Ascorbic acid - 60mg, Folic acid - 100mcg, Calcium phosphate - 100mg, Lecithin - 100mg, Magnesium sulfate - 10mg, Iron sulphate - 10mg, Copper sulfate - 2mg, Sodium selenite anhydrous - 50mcg, Zinc sulfate - 1mg		Capsule	1,342,499 L.L
A11CC05	VITEX D3	G	Vitamin D3 - 10,000IU	10,000IU	Capsule	447,500 L.L
A11CC05	VIT-X-FORTE	G	Vitamin D3 - 10,000IU	10,000IU	Capsule	895,895 L.L
B03AD	VITA-FERIN C	G	Ferrous fumarate - 300mg, Folic acid - 0.5mg, Vitamin C - 200mg		Capsule	716,268 L.L
N07XX08	VYNDAMAX	B	Tafamidis - 61mg	61mg	Capsule	784,020,041 L.L
C05CA05	VENOSMIL	G	Hidrosmin - 200mg	200mg	Capsule	976,973 L.L
C10AX06	VASCEPA	B	Eicosapentaenoic acid (Ethyl ester) - 1g	1g	Capsule	21,464,912 L.L
N03AX12	VOLAR	G	Gabapentin - 300mg	300mg	Capsule	1,100,607 L.L
N06AX16	VENLAX XR 150	G	Venlafaxine HCl - 150mg	150mg	Capsule, extended release	944,529 L.L
N06AX16	VENLAX XR 150	G	Venlafaxine HCl - 150mg	150mg	Capsule, extended release	1,416,794 L.L
N06AX16	VENLAX XR 37.5	G	Venlafaxine - 37.5mg	37.5mg	Capsule, extended release	383,955 L.L
N06AX16	VENLAX XR 37.5	G	Venlafaxine - 37.5mg	37.5mg	Capsule, extended release	575,933 L.L
N06AX16	VENLAX XR 75	G	Venlafaxine HCl - 75mg	75mg	Capsule, extended release	895,895 L.L
N06AX16	VENLAX XR 75	G	Venlafaxine HCl - 75mg	75mg	Capsule, extended release	1,343,843 L.L
N06AX16	VENLAFAXINE ARROW GENERIQUES LP	G	Venlafaxine - 150mg	150mg	Capsule, prolonged release	987,724 L.L
N06AX16	VENLAFAXINE ARROW GENERIQUES LP	G	Venlafaxine - 37.5mg	37.5mg	Capsule, prolonged release	1,075,074 L.L
N06AX16	VENLAFAXINE BIOGARAN LP	G	Venlafaxine HCl - 37.5mg	37.5mg	Capsule, prolonged release	538,881 L.L
N06AX16	VENLAFAXINE ARROW GENERIQUES LP	G	Venlafaxine - 75mg	75mg	Capsule, prolonged release	1,075,074 L.L
N06AX16	VENLAFAXINE BIOGARAN LP	G	Venlafaxine HCl - 75mg	75mg	Capsule, prolonged release	584,571 L.L
B01AB11	VESSEL DUE F TAB.	B	Sulodexide - 250LRU	250LSU	Capsule, soft gelatin	2,792,505 L.L
A11CC05	VIDROP	G	Vitamin D3 - 100IU/drop	100IU/drop	Drops	346,711 L.L
S02CA02	VIOCORTENE	B	Clioquinol - 10mg/ml, Flumetasone pivalate - 0.2mg/ml		Drops	568,253 L.L
S01AE07	VIGAMOX	G	Moxifloxacin (HCl) - 5mg/ml	5mg/ml	Drops solution	670,577 L.L
M02AA15	VOLDIC	G	Diclofenac sodium (diethylamine) - 10mg/g	1%	Emulgel	172,012 L.L
M02AA15	VOLTAREN EMULGEL 12HRS	B	Diclofenac Diethylamine - 23.2mg/g	23.2mg/g	Gel	1,169,143 L.L
S01AD09	VIRGAN	B	Ganciclovir - 1.5mg/g	1.5mg/g	Gel	804,962 L.L
M02AA15	VOLTAREN EMULGEL 12HRS	B	Diclofenac Diethylamine - 23.2mg/g	23.2mg/g	Gel	717,612 L.L
C05CA05	VENOSMIL	G	Hidrosmin - 2%	2%	Gel	588,603 L.L
R03AC02	VENTOLIN EVOHALER	B	Salbutamol (sulfate) - 100mcg/dose	100mcg/dose	Inhalation aerosol metered dose	260,705 L.L

...